DIASORIN SPA U/ADR

The global molecular diagnostics for infectious disease market is poised for growth, driven by advancements in biotechnology and genomics, as well as the impact of multiplex assays on diagnosis and treatment. The report covers dynamic trends, including pathogen evolution, globalization, and climate change impacts, and provides insights on the U.S. Medicare Fee Schedules and global data.

Related tickers: ABT, A, DHR, BDX, BIO, BIO.B, HOLX, QGEN, QDEL, RHHBY, SMMNY, TMO, DSRNY.

The global immunodiagnostics market is expected to grow significantly, driven by the rising prevalence of chronic and infectious diseases, the increasing need for point-of-care testing, and the surge in product launches.

Related tickers: TMO, ABT, RHHBY, BIO, BIO.B, DSRNY, DGX, DHR, MKKGY, SMMNY, BDX, QDEL.